Latest Financial Results News

St Barbara Limited reports steady gold production and strong financials while progressing the Simberi Expansion Project, though a PNG tax dispute delays funding decisions.

Alkane Resources reported steady gold production and cash flow for FY2025 at its Tomingley operations, while securing shareholder approval for a transformative merger with Mandalay Resources.

Rand Mining Ltd reported solid gold production of 8,916 ounces in the June 2025 quarter, alongside improved cash flow and ongoing exploration success at key Western Australian projects.

Entertainment Rewards Ltd reports a 6.1% revenue increase in Q4 FY25, driven by growth in key programs and a new $2.5 million loan facility, while narrowing its operating loss.

PolyNovo Limited reports a robust FY25 with nearly 29% sales growth, a significant cash increase to A$33.5 million, and expanding global market presence. The company’s strategic investments and product innovations signal strong momentum ahead.

Tribune Resources reported steady gold production of 8,916 ounces in the June 2025 quarter, alongside significant exploration drilling and a stronger cash position.

Oliver’s Real Food Limited reported a 70% increase in EBIT for the June 2025 quarter, driven by cost-cutting and operational improvements, despite a nearly 6% decline in revenue due to store closures and external factors.

Nova Eye Medical has reported a record A$29.2 million revenue for FY25, driven by strong sales growth and improved profitability in its glaucoma segment. The company targets breakeven EBITDA in the first half of FY26 alongside continued cash flow improvements.

Aurora Energy Metals has secured a six-month extension on Eagle Energy Metals' exclusive option for its flagship uranium project, accompanied by significant cash inflows and advancing metallurgical work. The company ends the quarter debt-free with a solid cash buffer as it pushes forward on multiple fronts.

N1 Holdings reports a profitable FY2025 with strategic expansion into Australia's largest aggregator panel and launches AI-driven credit tools to enhance SME lending operations.

Radiopharm Theranostics reports significant progress in its oncology radiopharmaceutical pipeline, including FDA Fast Track designation and dose escalation approvals, supported by a solid cash runway through mid-2026.

Liontown Resources reported robust FY25 results with over 294,000 dmt of spodumene concentrate produced and commenced underground mining on schedule. The company is transitioning to 100% underground production by Q3 FY26, aiming for scalable, low-cost operations from FY27 despite a 36% drop in spodumene prices.